PMWC 2019 Silicon Valley Session Themes

ScheduleShowcasesApply to Speak
AI and Data Sciences Showcase   Session Chair: Atul Butte, UCSF

AI and Data Sciences Showcase

Session Chair: Atul Butte, UCSF

Clinical Dx Showcase   Session Chair: Randy Scott, Invitae Corporation

Clinical Dx Showcase

Session Chair: Randy Scott, Invitae Corporation

Clinical & Research Tools Showcase   Session Chair: Stephen Quake, Stanford University

Clinical & Research Tools Showcase

Session Chair: Stephen Quake, Stanford University

Emerging Therapeutics Showcase   Session Chair: Feng Zhang, Broad Institute

Emerging Therapeutics Showcase

Session Chair: Feng Zhang, Broad Institute

Genomic Profiling Showcase   Session Chair: Preston Estep, Veritas Genetics

Genomic Profiling Showcase

Session Chair: Preston Estep, Veritas Genetics

Health Monitoring Showcase   Session Chair: Michael Snyder, Stanford Center of Genomics & Personalized Medicine

Health Monitoring Showcase

Session Chair: Michael Snyder, Stanford Center of Genomics & Personalized Medicine

Immunotherapy Showcase   Session Chair: Kimberly Blackwell, Lilly Oncology

Immunotherapy Showcase

Session Chair: Kimberly Blackwell, Lilly Oncology

Liquid Biopsy Showcase   Session Chair: Maximilian Diehn, Stanford University

Liquid Biopsy Showcase

Session Chair: Maximilian Diehn, Stanford University

Microbial Profiling Showcase   Session Chair: Rita R. Colwell, Johns Hopkins Bloomberg School of Public Health

Microbial Profiling Showcase

Session Chair: Rita R. Colwell, Johns Hopkins Bloomberg School of Public Health

Wellness and Aging Showcase   Session Chair: David S. Karow, Human Longevity

Wellness and Aging Showcase

Session Chair: David S. Karow, Human Longevity

Cancer Center Showcase – Precision Oncology Applications and Utility at Cancer Centers   Session Chair: James M. Ford, Stanford

Cancer Center Showcase – Precision Oncology Applications and Utility at Cancer Centers

Session Chair: James M. Ford, Stanford

Evolving Perspectives From The Beginning Of Personified Medicine   Session Chair: Ralph Snyderman, Duke University

Evolving Perspectives From The Beginning Of Personified Medicine

Session Chair: Ralph Snyderman, Duke University

The Present And The Future of Clinical Genomics Within US Health Systems   Session Chair: Aleksandar Rajkovic, UCSF Health

The Present And The Future of Clinical Genomics Within US Health Systems

Session Chair: Aleksandar Rajkovic, UCSF Health

Hurdles of Making Clinical Sequencing a Reality   Session Chair: Allison Ballmer, Agilent Tech

Hurdles of Making Clinical Sequencing a Reality

Session Chair: Allison Ballmer, Agilent Tech

Novel Hematologic Cancer Immunotherapies   Session Chair: Idit Sagiv-Barfi, Stanford University

Novel Hematologic Cancer Immunotherapies

Session Chair: Idit Sagiv-Barfi, Stanford University

Real World Evidence to Inform Research and Clinical Decision Making   Session Chair: Deborah Schrag, Harvard Medical School

Real World Evidence to Inform Research and Clinical Decision Making

Session Chair: Deborah Schrag, Harvard Medical School

Machine Learning and AI: An Investment Perspective   Session Chair: Ashley Van Zeeland, Illumina

Machine Learning and AI: An Investment Perspective

Session Chair: Ashley Van Zeeland, Illumina

The Need for Precision Medicine Workforce   Session Chair: Catherine Reinis Lucey, UCSF

The Need for Precision Medicine Workforce

Session Chair: Catherine Reinis Lucey, UCSF

Reimbursement Methodologies in Support of Precision Medicine   Session Chair: Rebecca Sutphen, InformedDNA

Reimbursement Methodologies in Support of Precision Medicine

Session Chair: Rebecca Sutphen, InformedDNA

Deploying NGS-based CDx Applications   Session Chair: Jeffrey Edward Miller, Invivoscribe, Inc.

Deploying NGS-based CDx Applications

Session Chair: Jeffrey Edward Miller, Invivoscribe, Inc.

Data Curation, Integration and Visualization   Session Chair: Brady Davis, DNAnexus

Data Curation, Integration and Visualization

Session Chair: Brady Davis, DNAnexus

Population-Based Biobanking   Session Chair: Clara Lajonchere, UCLA Institute for Precision Health

Population-Based Biobanking

Session Chair: Clara Lajonchere, UCLA Institute for Precision Health

Big Data Revolution in Drug Development: Reality or Hype?   Session Chair: David A. Shaywitz, Takeda Ventures, Inc.

Big Data Revolution in Drug Development: Reality or Hype?

Session Chair: David A. Shaywitz, Takeda Ventures, Inc.

Next In Personalized Medicine: Cancer-Phenotyping   Session Chair: Hartmut Juhl, Indivumed

Next In Personalized Medicine: Cancer-Phenotyping

Session Chair: Hartmut Juhl, Indivumed

Emerging Applications in Genomic Medicine   Session Chair: Rebecca Brandes, Agilent Technologies

Emerging Applications in Genomic Medicine

Session Chair: Rebecca Brandes, Agilent Technologies

Challenges In Applying AI On Biomedical Data   Session Chair: George Asimenos, DNAnexus

Challenges In Applying AI On Biomedical Data

Session Chair: George Asimenos, DNAnexus

Precision Imaging for Prediction   Session Chair: Andrew H. Beck, PathAI

Precision Imaging for Prediction

Session Chair: Andrew H. Beck, PathAI

AI Ethics & Privacy   Session Chair: Camille Nebeker, UCSD

AI Ethics & Privacy

Session Chair: Camille Nebeker, UCSD

New Model For Primary Care   Session Chair: Amir Dan Rubin, One Medical

New Model For Primary Care

Session Chair: Amir Dan Rubin, One Medical

DNA Testing for Cancer Screening   Session Chair: Adam Lowe, Chrysalis Biomedical Advisors

DNA Testing for Cancer Screening

Session Chair: Adam Lowe, Chrysalis Biomedical Advisors

Precision Medicine, Prevention, and Policy   Session Chair: India Hook-Barnard, UCSF

Precision Medicine, Prevention, and Policy

Session Chair: India Hook-Barnard, UCSF

Ethical Implications Of Using Whole Exome Sequencing In Prenatal And Young Children   Session Chair: Barbara Koenig, UCSF

Ethical Implications Of Using Whole Exome Sequencing In Prenatal And Young Children

Session Chair: Barbara Koenig, UCSF

IO Collaborative Group Trials   Session Chair: Kimberly Blackwell, Lilly Oncology

IO Collaborative Group Trials

Session Chair: Kimberly Blackwell, Lilly Oncology

Predictive Biomarkers and New Targets   Session Chair: Charles M. Perou, GeneCentric Therapeutics Inc.

Predictive Biomarkers and New Targets

Session Chair: Charles M. Perou, GeneCentric Therapeutics Inc.

Regulating T Cells and their Response to Cancer   Session Chair: Lawrence Fong, UCSF

Regulating T Cells and their Response to Cancer

Session Chair: Lawrence Fong, UCSF

Combinations with Other Modalities   Session Chair: Pamela Munster, UCSF

Combinations with Other Modalities

Session Chair: Pamela Munster, UCSF

Beyond PD-(L)1 Blockade   Session Chair: Leena Gandhi, Lilly Research Laboratories

Beyond PD-(L)1 Blockade

Session Chair: Leena Gandhi, Lilly Research Laboratories

Genetically Engineered T Cell-Based Therapies

Session Chair: Kara Davis, Stanford University

Cancer Neoantigen Vaccines   Session Chair: Andrew Allen, Gritstone Oncology

Cancer Neoantigen Vaccines

Session Chair: Andrew Allen, Gritstone Oncology

IO Intellectual Property   Session Chair: Catherine Polizzi, Morrison & Foerster

IO Intellectual Property

Session Chair: Catherine Polizzi, Morrison & Foerster

Empowering Researchers, Citizen, Scientists, and Patients Via Successful Data Sharing   Session Chair: Dawn Barry, LunaDNA

Empowering Researchers, Citizen, Scientists, and Patients Via Successful Data Sharing

Session Chair: Dawn Barry, LunaDNA

Data Sharing, Regulatory Compliance and Reimbursement   Session Chair: Patricia Goede, XIFIN, Inc.

Data Sharing, Regulatory Compliance and Reimbursement

Session Chair: Patricia Goede, XIFIN, Inc.

Enriching Genomics Data with Environmental, Behavioral, and Other Types of Data   Session Chair: Rita R. Colwell, Johns Hopkins

Enriching Genomics Data with Environmental, Behavioral, and Other Types of Data

Session Chair: Rita R. Colwell, Johns Hopkins

Fireside Chat: Carl June – Kim Blackwell   Session Chair: Carl June, University Pennsylvania

Fireside Chat: Carl June – Kim Blackwell

Session Chair: Carl June, University Pennsylvania

AI-driven Clinical Trial Design and Patient Selection   Session Chair: Janusz Dutkowski, Data4Cure

AI-driven Clinical Trial Design and Patient Selection

Session Chair: Janusz Dutkowski, Data4Cure

Scalable Infrastructure/Platforms to Power AI and Machine Learning on Big Data   Session Chair: Prabhat, NERSC

Scalable Infrastructure/Platforms to Power AI and Machine Learning on Big Data

Session Chair: Prabhat, NERSC

Overcoming Obstacles to Patient Data Sharing   Session Chair: Deven McGraw, Ciitizen

Overcoming Obstacles to Patient Data Sharing

Session Chair: Deven McGraw, Ciitizen

Data Collection Use Cases – Improved Patient Outcome   Session Chair: Judy Barkal, M2Gen

Data Collection Use Cases – Improved Patient Outcome

Session Chair: Judy Barkal, M2Gen

Genomics at Scale in the Clinical Setting   Session Chair: Shweta Singh Maniar, Google Cloud

Genomics at Scale in the Clinical Setting

Session Chair: Shweta Singh Maniar, Google Cloud

Applying Machine Learning to Predict Drug Development Success   Session Chair: Stacie Calad-Thomson, ATOM Consortium

Applying Machine Learning to Predict Drug Development Success

Session Chair: Stacie Calad-Thomson, ATOM Consortium

Ensuring Access to Genetic Counseling   Session Chair: Kaylene Ready, Myriad Women’s Health

Ensuring Access to Genetic Counseling

Session Chair: Kaylene Ready, Myriad Women’s Health

Fireside Chat: William Dalton – Atul Butte   Session Chair: William Dalton, M2Gen

Fireside Chat: William Dalton – Atul Butte

Session Chair: William Dalton, M2Gen

Next Gen Data Collection and Sharing   Session Chair: Crane Harris, San Diego Blood Bank

Next Gen Data Collection and Sharing

Session Chair: Crane Harris, San Diego Blood Bank

Proactive Genetic Testing for Mainstream Medical Practice   Session Chair: Robin Respaut, Reuters News

Proactive Genetic Testing for Mainstream Medical Practice

Session Chair: Robin Respaut, Reuters News

Demystifying AI in Pre-clinical Drug Design and Discovery   Session Chair: Brandon Allgood, Numerate, Inc

Demystifying AI in Pre-clinical Drug Design and Discovery

Session Chair: Brandon Allgood, Numerate, Inc

Emerging Tools for Immune Response Monitoring   Session Chair: George Karlin-Neumann, Bio-Rad Laboratories

Emerging Tools for Immune Response Monitoring

Session Chair: George Karlin-Neumann, Bio-Rad Laboratories

ScheduleShowcasesApply to Speak

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).